Montréal fundraising routes differ sharply between general technology, financial services, precision medicine and public financing. These 11 providers give founders a starting point without pretending that an angel network, venture builder and multi-stage fund work the same way.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
Montréal capital at a glance
This is a selective, unranked directory of 11 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| Real Ventures | Early-stage VC | Canadian technology |
| Inovia Capital | Multi-stage VC | Canada-anchored; North America and Europe |
| Brightspark Ventures | Early-stage VC | Canadian technology |
| Diagram | Venture builder and investor | Early-stage companies |
| Panache Ventures | Pre-seed and seed VC | Canada-wide |
| Luge Capital | Fintech VC | Canada and the United States |
| Anges Québec | Angel network | Québec startup ecosystem |
| Desjardins Capital | Investment and financing platform | Québec and local business development |
| Amplitude Ventures | Precision-medicine investor | Canadian healthcare; broader partnerships |
| BDC Capital | Venture platform | Canada-wide |
| Investissement Québec | Public investment and finance | Québec |
Choose the right conversation before choosing a contact
- A software company, therapeutic program and regulated fintech product need different evidence packages.
- A venture builder can participate in company formation; an existing-company fund evaluates a different relationship.
- Keep Québec public financing separate from private lead-investor work, even when both can support the same company.
Illustrative example: a Montréal precision-medicine spinout prepares a scientific development brief for healthcare specialists and a separate company financing brief for broader technology investors. It checks the university’s authorized IP information before sharing it. The team does not send the same consumer-software deck to every provider on the list.
Avoid this shortcut: An ecosystem program, a government finance product and an investment fund can have overlapping branding but different decision processes.
11 providers to research
1. Real Ventures
Early-stage VC. Canadian technology.
Real Ventures supports early-stage Canadian technology companies and describes a founder relationship beginning from day one. Real Ventures official information.
Prepare before outreach: Show a specific customer problem and why the founding team can learn faster than the alternatives.
2. Inovia Capital
Multi-stage VC. Canada-anchored; North America and Europe.
Inovia’s public approach spans discovery, venture and growth, from pre-seed to pre-IPO, across technology categories. Inovia Capital official information.
Prepare before outreach: Identify the appropriate strategy and team. Its fund-backing discovery activity is not the same route as a direct startup investment.
3. Brightspark Ventures
Early-stage VC. Canadian technology.
Brightspark backs Canadian early-stage technology companies and publishes examples beginning at pre-seed. Brightspark Ventures official information.
Prepare before outreach: Explain the evidence gained since inception and the assumptions the next round will test.
4. Diagram
Venture builder and investor. Early-stage companies.
Diagram both builds ventures from the ground up and invests in early-stage companies. Diagram official information.
Prepare before outreach: Clarify whether you seek investment in an existing business or a venture-building partnership; those are different working relationships.
5. Panache Ventures
Pre-seed and seed VC. Canada-wide.
Panache’s stated focus is early Canadian startup investing at pre-seed and seed. Panache Ventures official information.
Prepare before outreach: Present the initial product, customer learning and next financing milestone without overstating product-market fit.
6. Luge Capital
Fintech VC. Canada and the United States.
Luge invests in early-stage financial-technology companies in Canada and the US. Luge Capital official information.
Prepare before outreach: Make the financial workflow, customer and distribution advantage explicit, then discuss regulatory questions with qualified counsel.
7. Anges Québec
Angel network. Québec startup ecosystem.
Anges Québec offers a project-submission route and publishes investments across software, hardware and life sciences. Anges Québec official information.
Prepare before outreach: Prepare a concise application and identify the relevant sector experience in the network. Members are not separate guaranteed funding sources.
8. Desjardins Capital
Investment and financing platform. Québec and local business development.
Desjardins Capital supports businesses at startup, growth and transfer stages with equity and financing solutions. Desjardins Capital official information.
Prepare before outreach: State whether the need is risk equity, expansion capital or financing. Do not compare all its products as if they were one seed fund.
9. Amplitude Ventures
Precision-medicine investor. Canadian healthcare; broader partnerships.
Amplitude creates, builds and grows precision-medicine companies, spanning ideation through patient care. Amplitude Ventures official information.
Prepare before outreach: Lead with the scientific and translational evidence and a credible development plan, not a general health-software pitch.
10. BDC Capital
Venture platform. Canada-wide.
BDC Capital offers distinct venture strategies including seed, life sciences, industrial innovation and climate technology. BDC Capital official information.
Prepare before outreach: Choose the relevant fund rather than sending an undifferentiated application to the institution.
11. Investissement Québec
Public investment and finance. Québec.
Investissement Québec separates venture and development capital from loans, guarantees and government programs. Investissement Québec official information.
Prepare before outreach: Check the specific financing route and company criteria. An ecosystem support relationship does not establish eligibility for every instrument.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
Montréal investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my Montréal investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
A common founder question
Does a Québec connection guarantee eligibility?
No. Company location is one screening factor. Each fund or public financing route has its own current criteria and requires its own assessment.
How this list was researched
Research reviewed on October 28, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.